Index by category›
Research area
Approved peptide medicines — verification pilot
A source-gated pilot of approved peptide medicines and one biologic peptide mixture, verified independently from the imported discovery source.
These entries are the first publication batch from the PeptideGuide review queue. PeptideGuide was used only to discover candidates; identity, regulatory status, label facts and human evidence were checked against the primary sources linked on each page. Inclusion is not a recommendation to use a medicine.
Primary regulatory source
This is an educational reference, not individual medical advice. Use requires a prescriber and indication-specific monitoring.
9 peptides studied in this area
Exenatide
Byetta
An approved GLP-1 receptor agonist for glycemic control in adults with type 2 diabetes.
Pramlintide
Symlin
An approved amylin analog used with mealtime insulin in selected adults with type 1 or type 2 diabetes.
Salmon calcitonin
Calcitonin salmon
A synthetic salmon calcitonin medicine with limited, indication-specific FDA uses.
Triptorelin
Trelstar
An approved long-acting GnRH agonist depot used in the United States for palliative treatment of advanced prostate cancer.
Goserelin
Zoladex
An approved GnRH agonist delivered as a biodegradable subcutaneous implant.
Cetrorelix
Cetrotide
An approved GnRH antagonist used during controlled ovarian stimulation to prevent a premature LH surge and ovulation.
Menotropins (hMG)
Human menopausal gonadotropin
An approved biologic fertility medicine standardized by FSH and LH activity; it is a mixture, not one chemically defined peptide.
Lixisenatide
Adlyxin
A short-acting GLP-1 receptor agonist with a nuanced product history: U.S. approval and current label records coexist with the commercial withdrawal of the EU Lyxumia authorization.
Buserelin
Suprecur
A GnRH agonist authorized nationally in the United Kingdom for specialist fertility protocols; it is not FDA-approved or centrally authorized by EMA.